PATIENTS COME FIRST
For 119 years, The Woman’s Board of Northwestern Memorial Hospital has helped establish the hospital as one of the nation’s preeminent academic medical centers—one that prioritizes care and compassion for patients.
Through a current $3 million pledge, The Woman’s Board is improving patient experiences today—supporting young researchers through The Eleanor Wood-Prince Grant Initiative and bringing discoveries in the lab to cancer patients through the Developmental Therapeutics Program (DTP).
The Developmental Therapeutics Fellowship Program educates the next generation of collaborative physician scientists. Four of these fellows now lead the transformation of patient care in faculty positions across Chicago. Pictured clockwise from top left are Ricardo Costa, MD, Raquel Carneiro, MD, MS, Jason Kaplan, MD, and Aparna Kalyan, MD, MS.
Grant recipients Katherine Wisner, MD, MS, and Jackie K. Gollan, PhD, developed a phone-based treatment for women with Bipolar Disorder.
LAUNCHING SIGNIFICANT RESEARCH STUDIES
Established in 2001, The Eleanor Wood-Prince Grant Initiative highlights the power of seed grants. Four $25,000 grants are awarded annually to fund promising scientific ideas. These research initiatives’ outcomes are essential to securing funding for larger, more developed studies.
"We trained clinicians to deliver phone-based treatments for women with Depression or Bipolar Disorder. Using telepsychology, many women who suffered from mood disorders are now achieving a full recovery.”
— Jackie Gollan, PhD
TRAINING RESEARCHERS & ACCELERATING DISCOVERIES
The Developmental Therapeutics Program, launched with generous support from The Woman’s Board, accelerates access to breakthrough cancer therapies by working closely with Northwestern scientists and pharmaceutical partners. DTP has made significant progress since its inception in 2013.
"I feel incredibly lucky to be a part of a successful, established program. DTP allows us to build bridges between clinicians and scientists. We have the power to usher in a new era of personalized treatment for patients with cancer.”
— Young Chae, MD, MBA, MPH
Benedito Carneiro, MD, MS and Young Chae, MD, MBA, MPH, of the Developmental Therapeutics Program of the Division of Hematology/Oncology
HELP US CONTINUE TO PROVIDE INNOVATIVE TREATMENTS AND COMPASSIONATE CARE.
The Woman’s Board is committed to bringing innovative treatments and compassionate care to every patient at Northwestern Memorial Hospital. Your gift to the Annual Appeal will enable continued investments in groundbreaking work and exceptional patient care.